Introduction
Imagine noticing firm, raised bumps on your chest or neck. They look like scars, but you never had an injury there. They're not going away. They might even be spreading. That's what living with keloidal morphea can feel like, and it's a scenario that's more confusing than it sounds.
I first came across this condition while reading a case report about a 41-year-old woman who developed dark, hardened nodules on her chest and abdomen, along with tightening of the skin on her fingers. What struck me wasn't just the clinical details. It was how easily this could be mistaken for something else entirely. Keloidal morphea is one of those conditions that hides in plain sight, and that's exactly why it deserves more attention.
So let's talk about it. What is keloidal morphea? Who gets it? And why does getting the diagnosis right actually matter?
What Exactly Is Keloidal Morphea?
Keloidal morphea is a rare variant of morphea, which itself is a form of localized scleroderma, an autoimmune condition where the body's immune system triggers excess collagen production in the skin. In typical morphea, you'd see flat or sunken patches of hardened skin. But in keloidal morphea, the lesions are raised, nodular, and look a lot like keloids or hypertrophic scars.
Here's the twist: these lesions appear without any trauma or injury. That's a crucial detail. Unlike real keloids, which form after a cut, burn, or piercing, keloidal morphea nodules show up spontaneously. They most commonly appear on the neck, trunk, and proximal extremities, though they can show up elsewhere too.
Alternative names you might come across include keloidal scleroderma, nodular morphea, and nodular scleroderma. They all refer to the same clinical picture.
Symptoms: What Does It Actually Look Like?
The lesions in keloidal morphea are usually firm, raised, and can vary in size. Some are painless, while others itch or feel tender. In the case I mentioned earlier, the patient had dark brown, indurated nodules with a slight violaceous (purplish) border on her chest and breasts, along with smaller hyperpigmented plaques scattered across her abdomen.
Many patients also show signs of sclerodactyly, which is tightening and thickening of the skin on the fingers. Raynaud's phenomenon, where fingers turn white or blue in response to cold or stress, can also be present.
But here's where it gets complicated. Because these nodules look so much like keloids, and because keloidal morphea most often affects people with skin of color, there's a real risk of misdiagnosis. Research suggests that keloidal morphea is significantly underrecognized in these populations, contributing to health disparities in dermatologic care.
Who Gets It?
Based on a review of 43 reported cases, the majority of patients were African American and female. The trunk was the most common site of involvement, and about 63% of patients tested positive for antinuclear antibodies (ANA).
The condition can occur at any age, but many cases present in adulthood. A recent report described a 26-year-old Black woman with Raynaud's syndrome who developed pruritic plaques on her abdomen, thigh, and chest over a period of 1.5 years. Another case involved an 18-year-old male with a linear, firm plaque on his neck that had been present for six months.
The takeaway? Keloidal morphea doesn't discriminate by age, but it does show a clear predilection for women and individuals with darker skin tones.
What Causes It? The Science Behind the Scarring
The exact cause of keloidal morphea isn't fully understood, but there are some compelling theories. One involves an abnormal dermal inflammatory process that triggers sclerosis and keloid-like lesion formation. Another points to microtrauma and inflammation leading to excessive fibrosis.
At a molecular level, transforming growth factor-beta (TGF-β), a cytokine that plays a key role in collagen synthesis, is heavily implicated. Increased expression of connective tissue growth factor has been found in lesional fibroblasts from patients with nodular scleroderma. Some researchers also suggest that the activated fibroblasts in keloidal morphea might originate from circulating bone marrow-derived progenitor cells, which could explain why lesions sometimes appear in a scattered distribution.
In short, this isn't just a skin problem. It's a complex interplay between the immune system, connective tissue, and wound-healing pathways gone awry.
How Is Keloidal Morphea Diagnosed?
Diagnosis is tricky. Clinically, keloidal morphea can be confused with keloids, hypertrophic scars, sarcoidosis, and even sclerotic dermatofibroma. A skin biopsy is usually necessary to confirm the diagnosis.
Histologically, you might see dermal fibroplasia, proliferation of capillaries and fibroblasts, and a loss of the CD34 dermal dendritic cell network. Some biopsies show thickened, hyalinized collagen bundles with reduced adnexal structures and perivascular or peri-eccrine inflammatory infiltrates. In other words, the biopsy can show features of both morphea and keloid scarring, which is exactly why clinicopathological correlation is so important.
Blood tests may also be done. ANA positivity is common, and about 28% of patients in one review had pulmonary involvement, so a thorough systemic evaluation is warranted.
Treatment Options: What Works?
Here's the honest truth: there's no consensus on the best treatment for keloidal morphea, and results are variable. That said, several approaches have been tried with some success.
Topical corticosteroids are often the first line, sometimes combined with calcipotriene cream. Intralesional steroid injections can help reduce nodule size and firmness. Methotrexate, either alone or with systemic steroids, has shown promise, particularly in progressive cases.
Other options include narrowband UVB therapy, tacrolimus ointment, calcitriol, and UVA1 phototherapy. In one case, methotrexate combined with systemic steroids led to a partial response within 12 weeks.
The key is early intervention. Late-stage sclerotic lesions respond poorly to treatment, so timely diagnosis and management are critical.
Why This Matters
Keloidal morphea isn't just a cosmetic concern. It can be disfiguring, and in some cases, it's associated with systemic sclerosis and internal organ involvement. The fact that it disproportionately affects people with skin of color, who already face barriers to timely dermatologic care, makes awareness even more important.
If you or someone you know develops firm, raised nodules on the trunk or neck without a history of trauma, it's worth getting checked out. It might be a keloid. It might be something else. But getting the right diagnosis early can make a real difference.
FAQs
1. Is keloidal morphea the same as a keloid?
No. While they look similar, keloids form after skin injury, whereas keloidal morphea lesions appear spontaneously without trauma. They also have different underlying causes and require different management approaches.
2. Is keloidal morphea contagious?
Not at all. It's an autoimmune-related condition, not an infection. You can't catch it from someone else.
3. Can keloidal morphea go away on its own?
In some cases, lesions may stabilize or partially improve, but they rarely resolve completely without treatment. Early intervention gives the best chance of controlling the condition.
4. Does keloidal morphea mean I have systemic sclerosis?
Not necessarily. Some patients with keloidal morphea also have systemic sclerosis, but many do not. Your doctor may recommend blood tests and other evaluations to check for systemic involvement.
5. Who should I see if I suspect keloidal morphea?
A dermatologist is your best first stop. They can perform a biopsy and, if needed, refer you to a rheumatologist for further evaluation.
This article is for informational purposes only and should not replace professional medical advice. If you have concerns about your skin, please consult a qualified healthcare provider.
Sign in to leave a comment.